Antifibrotic treatments have similar effects in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.

The main pulmonary artery diameter, esophageal dilatation, and ILD score are independent risk factors for 5-year all-cause mortality in patients with connective tissue disease-associated PAH.

The burden of interstitial lung disease has increased globally over the past 30 years and is positively linked to socio-demographic index (SDI).

Patients newly diagnosed with PAH are often undertreated relative to treatment recommendations outlined in current guidelines.

When is it too late for a patient to file a malpractice claim? It is sometimes unclear when the statute of limitations ...

According to a new study, the score can accurately predict long-term outcomes in patients with IPF and ILD associated with connective tissue disease.

South Carolina’s fast-growing measles outbreak has now reached a major college campus after health officials confirmed a case ...

Multiple breath washout was done in 10% of Europeans with cystic fibrosis in 2023, mostly in children and in adults with near ...

Quantitative CT metrics can be used to define progressive pulmonary fibrosis and have prognostic value in patients with ...

Medical resident Jared Dashevsky's Healthcare Huddle newsletter helps physicians navigate business and tech forces shaping ...

Early management of obstructive sleep apnea in patients with IPF could slow disease progression and improve outcomes.

In 2024, 31.7 % of adults and 29.5% of children had a diagnosed seasonal allergy, diagnosed eczema, or a diagnosed food ...